SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-227652
Filing Date
2023-09-01
Accepted
2023-09-01 16:12:56
Documents
2
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.INVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.MR. AMAURY WITTOUCKSTICHTING ADMINISTRATIEKANTOOR WESTENDWESTEND S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G d546378dsc13g.htm SC 13G 139886
2 EX-99.1 d546378dex991.htm EX-99.1 9893
  Complete submission text file 0001193125-23-227652.txt   151683
Mailing Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661
Business Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661 352224259-1
Artal International S.C.A. (Filed by) CIK: 0001218180 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Subject) CIK: 0001479615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13G | Act: 34 | File No.: 005-92205 | Film No.: 231232670
SIC: 2834 Pharmaceutical Preparations